Evidence map›Paper›PMID 38414944›Full record

ArticleEcancermedicalscience2023

Antenatal and postnatal cervical precancer screening to increase coverage: experience from Battor, Ghana.

Kofi Effah, Ethel Tekpor, Gifty Belinda Klutsey, Hannah Tiwaah Bannor, Joseph Emmanuel Amuah, Comfort Mawusi Wormenor, Seyram Kemawor, Stephen Danyo, Bernard Hayford Atuguba, Lawrencia Serwaa Manu and 2 more

Abstract read
In one paragraph

Article in Ecancermedicalscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kofi EffahCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Ethel TekporCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Gifty Belinda KlutseyCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Hannah Tiwaah BannorCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Joseph Emmanuel AmuahCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Comfort Mawusi WormenorCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Seyram KemaworCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Stephen DanyoCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Bernard Hayford AtugubaCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Lawrencia Serwaa ManuCatholic Hospital, Battor, PO Box 2, Battor, via Sogakope, Volta Region, Ghana.
Nana Owusu Mensah EsselDepartment of Emergency Medicine, College of Health Sciences, Faculty of Medicine and Dentistry, University of Alberta, 730 University Terrace, Edmonton, AB T6G 2T4, Canada.
Patrick Kafui AkakpoDepartment of Pathology, Clinical Teaching Center, School of Medical Sciences, University of Cape Coast, Cape Coast, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cervical precancer screening in low-resource settings is largely opportunistic with low coverage. Many women in these settings, where the burden of cervical cancer is highest, only visit health institutions when pregnant or after delivery. We explored screening during antenatal and postnatal visits aimed at increasing coverage. Methods: Pregnant women (in any trimester) attending antenatal care (ANC) and women attending postnatal care (PNC; 6-10 weeks) clinics were screened at Catholic Hospital, Battor and at outreach clinics from February to August 2022 (08/02/2022 to 02/08/2022). At the same visit, cervical specimens were obtained for high-risk human papillomavirus (hr-HPV) DNA testing (with the Sansure MA-6000 PCR platform) followed by either visual inspection with acetic acid (VIA) or mobile colposcopy with the enhanced visual assessment system. Results: Two hundred and seventy and 107 women were screened in the antenatal and postnatal groups, respectively. The mean ages were 29.4 (SD, 5.4) in the ANC group and 28.6 (SD, 6.4) years in the PNC group. The overall hr-HPV prevalence rate was 25.5% (95% confidence interval (CI), 21.1-29.9) disaggregated as 26.7% (95% CI, 21.4-31.9) in the ANC group and 22.4% (95% CI, 14.5-30.3) in the PNC group ( Conclusion: A significant number of women in Ghana only visit a health facility during pregnancy or after delivery. ANC and PNC clinics would offer opportunities to increase coverage in cervical precancer screening in low-resource settings. Relying on community nurses ensures that such programs are readily integrated into routine care of women and no opportunity is missed.

Indexed as

colposcopyhuman papillomavirus DNA testinghuman papillomavirus infectionpostnatal careprenatal careuterine cervical neoplasm

Identifiers

PMID38414944
PMCPMC10898892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.